A recent report of the EuroHeart project has shown that women are still underrepresented in
many cardiovascular clinical trials, while important gender differences are present within …

Cardiovascular diseases represent the major cause of mortality in women and in men. 1, 2
However, gender differences in the clinical presentation of cardiovascular diseases have …

Cardiovascular disease develops 7 to 10 years later in women than in men and is still the
major cause of death in women. The risk of heart disease in women is often underestimated …

For many years the significance of heart disease in women was vastly underappreciated,
and women were significantly underrepresented in cardiovascular clinical research. We now …

Cardiovascular diseases (CVD) are the leading cause of mortality both in men and women.
In Europe, about 55% of all females' deaths are caused by CVD, especially coronary heart …

Cardiovascular disease (CVD) is the leading cause of death in women, and knowledge of
the clinical consequences of atherosclerosis and CVD in women has grown tremendously …

After at least 2 decades of growing awareness on coronary heart disease in women, we are
left with many questions, few answers, and plenty of opinions. Review articles, books …

Over the past decade, scientists, healthcare providers, the public, and policy makers have
made substantial efforts to improve understanding of the sex/gender* differences in …

Cardiovascular disease (CVD) is the leading cause of premature death for women in
Canada. 1 Although it has long been recognized that estrogen impacts vascular responses …

Gender-specific data focused on cardiovascular disease (CVD) are becoming increasingly
available. This is of great importance, given that CVD has become the number 1 killer of …